The Cooper Companies found using ticker (COO) have now 12 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The target price ranges between 560 and 310 with a mean TP of 407.58. Given that the stocks previous close was at 313.44 this would indicate that there is a potential upside of 30.0%. There is a 50 day moving average of 322.01 and the 200 day MA is 381.14. The market capitalisation for the company is $15,477m. Find out more information at: https://www.coopercos.com
The potential market cap would be $20,126m based on the market concensus.
The Cooper Companies, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women’s health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies was founded in 1958 and is headquartered in San Ramon, California.
